Why identification of stroke syndromes is still important

Current Opinion in Neurology

Volumn 20, Issue 1, 2007, Pages 78-82

  Kumar, Sandeep ^a   Caplan, Louis R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Randomized trials; Stroke subtyping; Stroke syndromes

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; THROMBIN INHIBITOR;

BRAIN ISCHEMIA; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DECISION MAKING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; REVIEW; STROKE; SYMPTOM; ULTRASOUND;

ADULT; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DECISION MAKING; DECISION SUPPORT SYSTEMS, CLINICAL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MALE; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 33846143835     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328013e964     Document Type: Review

References (55)

1. Caplan L. Evidence based medicine: concerns of a clinical neurologist [editorial]. J Neurol Neurosurg Psychiatry 2001; 71:569-576.
2. Llinas R, Caplan LR. Evidence-based treatment of patients with ischemic cerebrovascular disease. Neurol Clin 2001; 19:79-105.
3. Fields WS, Lemak N, Frankowski R, et al. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8:301-306.
4. Barnett HJM. The Canadian Cooperative Study: a randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299:53-59.
5. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143:1-13.
6. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events. Lancet 1996; 348:1329-1339.
7. Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321:501-507.
8. Gent M, Easton JD, Hachinski V, et al. The Canadian American Ticlopinine Study (CATS) in thromboembolic stroke. Lancet 1989; 1:1215-1220.
9. Bezerra DC, Bogousslavsky J. Antiplatelets in stroke prevention: the MATCH trial. Some answers, many questions and countless perspectives. Cerebrovasc Dis 2005; 20 (Suppl 2):109-118.
10. Caplan LR. Thrombolysis 2004: the good, the bad, and the ugly. Rev Neurol Dis 2004; 1:16-20.
11. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
12. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017-1025.
13. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS ll). Lancet 1998; 352:1245-1251.
14. Adams H, Adams R, Del Zoppo G, Goldstein LB. Stroke Council of the American Heart Association; American Stroke Association Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke association. Stroke 2005; 36:916-923.
15. Gottesman RF, Sherman PM, Grega MA, McKhann, et al. Watershed strokes after cardiac surgery: diagnosis, etiologyandoutcome. Stroke 2006; 37:2306-2311.
16. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med 1991; 325:445-453.
17. Fisher CM. Lacunes: small, deep cerebralin farcts. Neurology 1965; 15:774-784.
18. Caplan LR, Tettenborn B. Vertebrobasilar occlusive disease: spontaneous dissection of extracranial and intracranial posterior circulation arteries. Cerebrovascular Diseases 1992; 2:256-265.
19. Leary M, Caplan LR. Cerebrovascular disease and neurologic manifestations of heart disease. In: Fuster V, Alexander RW, O'Rourke RA, editors. Hurst's the heart, 11th ed. New York: McGraw-Hill; 2004. pp. 2323-2348.
20. Pullicino P, Halperin J, Thompson J. Stroke in patients with heart failure and reduced left ventricular ejection fraction. Neurology 2000; 54:288-298.
21. Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke 2006; 37:1715-1719.
22. Dries DL, Rosenberg YD, Waclawiw MA, Domanski MJ. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm. J Am Coll Cardiol 1997; 29:1074-1080.
23. Amarenco P, Cohen A, Bousser MG. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994; 331:1474-1479.
24. Mas JL. Diagnois and management of paradoxical embolism and patent foramen ovale. Curr Opin Cardiol 1996; 11:519-524.
25. Ehtisham A, Stern BJ. Cerebral venous thrombosis: a review. Neurologist 2006; 12:32-38.
26. Waddy SP. Disorder of coagulation in stroke. Semin Neurol 2006; 26:57-64.
27. Britton M, Hindmarsh T, Tyden SA. Diagnostic errors discovered by CT in patients with suspected stroke. Neurology 1984; 34:1504-1507.
28. Caplan LR. Charles Foix - the first modern neurologist. Stroke 1990; 21:348-356.
29. Osler W. The principles and practice of medicine. 5th ed. New York: D Appleton; 1903.
30. Gowers WR. A manual of disease of the nervous system. London: J and A Churchill; 1893.
31. Wilson SAK, Bruce AN. Neurology. 2nd ed. London: Butterworth-Heinemann; 1955.
32. Kubik CS, Adams RD. Occlusion of the basilar artery: a clinical and pathological study. Brain 1946; 69:73-121.
33. Fisher CM. Occlusion of the internal carotid artery. Arch Neurol 1951; 65:346-377.
34. Fisher CM. Clinical syndromes in cerebral hemorrhage. In: Fields W, editor. Pathogeneiss and treatment of cerebrovascular diseases. Springfield: Charles C Thomas; 1961. pp. 318-342.
35. Fisher M, Prichard JW, Warach S. New magnetic resonance techniques for acute ischemic stroke. JAMA 1995; 274:908-911.
36. Schellinger PD, Fiebach JB, Jansen O, et al. Stroke magnetic resonance imaging within 6 h after onset of hyperacute cerebral ischemia. Ann Neurol 2001; 49:460-469.
37. Neumann-Haefelin T, Moseley ME, Albers GW. New magnetic resonance Imaging methods for cerebrovascular disease: emerging clinical applications. Ann Neurol 2000; 47:559-570.
38. Wintermark M, Reichhart M, Thiran J-P, et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann Neurol 2002; 51:417-432.
39. Koroshetz W. Contrast computed tomography scan in acute stroke: "You can't always get what you want but. . .you get what you need". Ann Neurol 2002; 51:415-416.
40. Klein IF, Lavellee PC, Schouman-Claeys E, Amaraenco P. High-resolution MRI identifies basilar artery plaques in paramedian pontine infarct. Neurology 2005; 64:551-552.
41. Klein IF, Lavallee PC, Touboul P-J, et al. In vivo middle cerebral artery plaque imaging by high-resolution MRI. Neurology 2006; 67:327-329.
42. Goldstein LB, Adams R, Alberts MJ, et al. American Heart Association; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006 20;113:e873-923.
43. Stroke 2006; 37:1583-1633. This provides an overview of potential stroke risk factors and recommendations for risk reduction.
44. Bauer KA. New anticoagulants: anti IIa vs anti Xa - is one better? J Thromb Haemostat 2005; 3:436-438.
45. Molina CA, Saver JL. Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke 2005; 36:2311-2320.
46. Tereda T, Tsuura M, Yamaga H, et al. Endovascular therapy for stenosis of the petrous or cavernous portion of the internal carotid artery: percutaneous transluminal angioplasty compared with stent placement. J Neurosurg 2003; 98:491-497.
47. Chong PL, Salhiyyah K, Dodd PD. The role of carotid endarterectomy in the endovascular era. Eur J Vasc Endovasc Surg 2005; 29:597-600.
48. Al-Mubarak N, Roubin GS, New G, et al. Techniques of carotid stenting: the state of art. Semin Vasc Surg 2000; 13:117-129.
49. Caplan LR. Top of the basilar syndrome: selected clinical aspects. Neurology 1980; 30:72-79.
50. Mehler MF. The rostral basilar artery syndrome: diagnosis, etiology, prognosis. Neurology 1989; 39:9-16.
51. Schellinger PD, Hacke W. Intra-arterial thrombolysis is the treatment of choice for basilar thrombosis. Stroke 2006; 37:2436-2437.
52. Hacke W, Zeumer H, Zoppo G, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebro-basilar occlusive diseases. Stroke 1988; 19:1216-1222.
53. Brandt T, von Kummer R, Hacke W, et al. Thrombolytic therapy of acute basilar occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27:875-881.
54. Arnold M, Nedeltchev K, Mattle HP. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004; 75:857-862.
55. Breen JC, Caplan LR, DeWitt LD, et al. Brain edema after carotid surgery. Neurology 1996; 46:175-181.